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INTRODUCTION
Children undergoing operations may suffer from severe
pain as well as fear and anxiety even after minor surgery;
therefore, inadequate analgesia may cause greater physical
and emotional stress on children than adults (1). In the past,
the conventional pain management was achieved with the
intermittent injection of analgesics. Concerns about opioid
overdose often result in suboptimal analgesia due to dose
errors and dosage interval errors. Lack of experience and ina-
bility to assess pain in non-verbal children has contributed
to the inadequate provision of analgesia in this group. Though
patient-controlled analgesic (PCA) device has now become
the primary modality for the management of moderate to
severe postoperative pain in older children and adolescents
(2, 3), continuous intravenous opioid infusions are still re-
served these days for preverbal children who cannot handle
the PCA devices. Recently, parent- or nurse-controlled anal-
gesia with opioid showed some advantages over the contin-
uous opioid infusion (4). Since adequate assessment of pain
and analgesic response is a critical component of pain man-
agement in preverbal children, parent-controlled analgesia
(PrCA) still remains as a practical challenge in pediatric anes-
thesia.
Cleft palate repair common in 1-2 yr old children, involv-
ing the soft and hard palate, requires postoperative pain man-
agement (5). Therefore, it is worthwhile to develop a proce-
dure-specific postoperative pain management regimen for
these preverbal patients (6).
The aims of this study were to find an optimal basal infu-
sion dose of fentanyl for PrCA in preverbal patients under-
going cleft palate repair and the level of parents’ satisfaction
with participating in PrCA for their children.
MATERIALS AND METHODS
Subjects and intraoperative care
This study was approved by the institutional review board,
and informed consent was obtained from parents after explain-
ing the study protocol. On the day of pre-anesthetic visit,
the parents were taught the principles of PCA devices and
their role in the study; such as how to give bolus doses, how
to monitor the efficacy of analgesia, and also how to identify
adverse effects during the study periods. Parents were well-
educated and tested how to handle the PCA device for this
study.
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Parent-Controlled Analgesia in Children Undergoing Cleft Palate Repair
The aims of this study were to find an optimal basal infusion dose of fentanyl for
parent-controlled analgesia (PrCA) in children undergoing cleft palate repair and
the degree of parents’ satisfaction with PrCA. Thirty consecutive children between
6 months and 2 yr of age were enrolled. At the end of surgery, a PrCA device with
a basal infusion rate of 2 mL/hr and bolus of 0.5 mL with lockout time of 15 min was
applied. Parents were educated in patient-controlled analgesia (PCA) devices, the
Wong Baker face pain scoring system, and monitoring of adverse effects of fentanyl.
Fentanyl was infused 0.3 g/kg/hr at first, and we obtained a predetermined fen-
tanyl regimen by the response of the previous patient to a larger or smaller dose of
fentanyl (0.1 g/kg/hr as the step size), using an up-and-down method. ED50 and
ED95 by probit analysis were 0.63 g/kg/hr (95% confidence limits, 0.55-0.73 g/
kg/hr) and 0.83 g/kg/hr (95% confidence limits, 0.73-1.47 g/kg/hr), respectively.
Eighty seven percent of the parents were satisfied with participating in the PrCA
modality. PrCA using fentanyl with a basal infusion rate of 0.63 g/kg/hr can be
applied effectively for postoperative pain management in children undergoing cleft
palate repair with a high level of parents’ satisfaction.
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Thirty consecutive children between 6 months and 2 yr
of age who underwent cleft palate repair were enrolled in
this study. All children were ASA physical status I or II, and
born at full term. Children with apnea history, Pierre-Robin
syndrome, or any congenital heart or neurological diseases
were excluded (7). Premedication was not prescribed. Intra-
venous catheterization was performed at ward. All patients
were monitored with electrocardiography, noninvasive blood
pressure, and pulse oximetry when they arrived in the oper-
ating room. Anesthesia was induced with thiopental sodium
5 mg/kg, and rocuronium 0.6 mg/kg was given intravenous-
ly for neuromuscular blockade. After endotracheal intuba-
tion, the lungs were ventilated with 50% air in oxygen and
sevoflurane. For intraoperative pain control, the incision sites
were infiltrated with lidocaine by the surgeon. After the com-
pletion of the operation, neuromuscular block was reversed
with neostigmine 0.03 mg/kg and atropine 0.01 mg/kg. 
Study designs and protocol
Before sending the children to the post-anesthetic care unit,
the PCA pump (Accufuser�, Woo Young Medical, Seoul,
Korea) with a fixed basal infusion rate of 2 mL/hr and bolus
of 0.5 mL with lockout time of 15 min as rescue therapy was
attached to a continuously infusing intravenous catheter. The
fentanyl regimen was coded on the basal infusion rate of fen-
tanyl: for example, ‘fentanyl regimen 0.3’ notes a basal infu-
sion of 0.3 g/kg/hr and bolus injections on demand, dose
of quarter of basal infusion with lockout time of 15 min.
PCA pump was set initially as ‘fentanyl regimen 0.3’, and
the next regimen was predetermined by the response of the
previous patient to a larger or smaller dose (with ‘fentanyl
regimen 0.1’ as a step size), using a modification of the Dixon’s
up-and-down method (8). The patient’s response to the fen-
tanyl regimen was evaluated by parents according to the
Wong-Baker face pain rating scale of 10 at resting state, as
being 10 with maximal pain and 0 with no pain (9). Pain
score was recorded by parents at 2-hr intervals for the first
12-hr, at 6-hr intervals for the second 12-hr and every 12-hr
thereafter until 48 hr. We defined the patient’s response to
the PCA regimen as ‘Effective’ or ‘Not effective’. ‘Effective’
refers to average pain score less than 5 for 2 days and ‘Not
effective’ refers to greater than or equal to 5. If further anal-
gesia is required, ibuprofen syrup (5 mg/kg) was adminis-
tered on demand.
The observed Effective Dose50 (EDo50) for the fentanyl regi-
men was estimated by calculating the average of cross-over
midpoints of fentanyl regimens of all independent pairs of pati-
ents involving a cross-over (i.e. ‘Effective’ to ‘Not effective’).
Assessment of adverse responses and questionnaire of
parents’ satisfaction with PrCA
The degree of sedation was assessed by parents, by using
four-point patient sedation score (PSS) at 6-hr intervals (10).
The PSS was assigned as follows: 1=asleep, not arousal by
verbal contact; 2=asleep, arousal by verbal contact; 3=drowsy/
not sleeping; and 4=alert/aware. The PSS was used to quan-
tify sedation and also help identify side effects, such as res-
piratory depression from excessive sedation. Occurrences of
side effects such as vomiting or respiratory depression were
recorded at 6-hr intervals. If the patient had side effects, infu-
sion would be immediately stopped and the appropriate man-
agement would be taken and recorded. Because of concerns
about the potential for respiratory depression, supplemental
oxygen and naloxone were prepared on an as-needed basis for
all patients. If the patient had vomiting, ondansetron 0.1 mg/
kg was administered. At the completion of study, a question-
naire on the satisfaction of parents was recorded with four-
point rating scale (excellent=1, good=2, fair=3, and poor=4). 
Statistical analysis
For statistical analysis, analysis of variance and multiple
comparisons using Bonferroni’s correction were used. We
also used a probit analysis (SPSS 12.0; SPSS Inc., Chicago,
IL, U.S.A.) in order to obtain the probability of 50% and
95% effectiveness of pain relief (predicted Effective Dose
EDp50 and EDp95) and 95% confidence limits. For sample size
calculation, we estimated that a minimum of 25 patients
would be required to maintain the limit of error of estimat-
ed EDp50 <0.2 for an up-and-down sequential allocation
design. All data were expressed as mean±SD or number of
responses, as appropriate. A p value <0.05 was considered as
statistically significant.
RESULTS
The mean age of the patients was 1.2±0.2 yr old, mean
body weight was 10.2±1.1 kg, and the gender ratio was
14:16 (male:female). The observed ED50 (EDo50) was 0.66±
0.08 g/kg/hr (Fig. 1), and the dose-response plot, construct-
ed on the basis of probit analysis data (Fig. 2), showed that
the EDp50 and EDp95 of the fentanyl regimen were 0.63 g/
kg/hr (95% confidence limits, 0.55-0.73 g/kg/hr) and 0.83
g/kg/hr (95% confidence limits, 0.73-1.47 g/kg/hr) along
with an equation plot of probit (response=-1.54+3.1×‘fen-
tanyl regimen’ and r2=0.95), respectively. Maximum likeli-
hood estimators of the probit model variables showed a p value
of 0.593 and a goodness of fit chi-square of 0.964. EDo50 was
similar to EDp50. Most of bolus injections were administered
only during the first postoperative day, and the total dose of
fentanyl consumption during the first day increased propor-
tionally to fentanyl regimens (p<0.05) (Table 1). Three patients
(25%) managed with fentanyl regimen 0.7 (one) or 0.8 (two),
experienced vomiting on the day of surgery and were effec-
tively treated with ondansetron 0.1 mg/kg. None of the pati-
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ents was apneic or over-sedated (PSS <2). Eighty seven per-
cent of parents were satisfied with the participation in the
PrCA modality (excellent or good) (Table 2).
DISCUSSION
PrCA modality in preverbal children
The framework of PrCA using PCA devices consists of
continuous basal infusions and bolus injections on a demand
basis by parents. The role of parents in this study was to eval-
uate the analgesic response of their child to the basal infu-
sion of fentanyl, administer bolus injections on a demand
basis, and also to monitor the appearance of adverse effects
such as respiratory depression, nausea, and vomiting. We
employed the Wong-Baker face pain rating scale (8) as the
pain assessment tool for parents because of its simplicity and
non-reliance on confusing physiological parameters which
would be inappropriate for parents (11). 
Fentanyl regimen as analgesic agent in PrCA for prever-
bal patients
With regard to the agent of PrCA regimen for preverbal
children, avoidance of the adverse effects of opioid is as im-
portant as relief of pain. A short-acting opioid such as fen-
tanyl is preferred to long-acting opioid such as morphine and
hydromorphone, because fentanyl does not have any signifi-
cant adverse effects on the cardiovascular system and its me-
tabolites do not include active forms. 
In our study, EDo50 and EDp50 were similar. The EDp50 and
EDp95 of the fentanyl regimen were 0.63 and 0.83 g/kg/hr,
respectively. The ED50 in our study was different from the
median infusion dose (fentanyl 0.86 g/kg/hr) of surgical
patients less than 6 yr of age (12). This difference could be
explained by pharmacokinetic differences of fentanyl by age
(13), different types of surgery and statistical parameters. We
also measured the number of bolus injections and total con-
sumption dose of fentanyl. Most patients were administered
with bolus injections only during the first 12 hr. The total
consumption dose of fentanyl was increased proportionally,
and the bolus doses were decreased proportionally, to fentanyl
regimens (Table 1). This implies optimal basal infusion could
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Fig. 2. Probit analysis of fentanyl regimen. Triangles in the bottom
represent the patients of ‘Not effective’, and reverse triangles in
the top represent the patients of ‘Effective’. Regression plot and
line were displayed according to probit analysis.
Fentanyl regimen 
(No. of patient)
Total consumption dose
of fentanyl ( g/kg) 
0.3 (n=1) 9.56
0.4 (n=1) 13.2
0.5 (n=5) 13.5±0.5
0.6 (n=11) 15.2±1.2*
0.7 (n=9) 17.6±0.5�
0.8 (n=3) 20.6±0.3�
Table 1. Total consumption dose of fentanyl with different fen-
tanyl regimens
Values are mean±SD (total dose) and the number of patients. *p<0.05
vs. fentanyl regimen 0.5; �p<0.001 vs. fentanyl regimen 0.5 and 0.6; �p<
0.001 vs. fentanyl regimen 0.5, 0.6 and 0.7. Data were obtained during
the first postoperative day, and the fentanyl regimen 0.3 and 0.4 were ex-
cluded from statistical comparison because of the small sample size.
Number of parents (n=30)
Excellent 11
Good 15
Fair 4
Poor 0
Table 2. Parents’ satisfaction for parent-controlled analgesia
Fig. 1. The responses of 30 consecutive patients by the parent-
controlled analgesic (PrCA) modality with different fentanyl regi-
mens. Patient’s response to the PrCA regimen was described as
‘Effective’ (open circle) or ‘Not effective’ (close circle). Fentanyl
regimen was coded by the numeric of the basal infusion rate ( g/
kg/hr). Arrows indicate the midpoint of fentanyl regimens of all
independent pairs of patients, involving a crossover from ‘Not
effective’ to ‘Effective’.
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decrease the bolus requirements and improve overall quality
of analgesia (14). As the confidence limits of ED95 were in a
wide range, the ED50 of fentanyl regimen was recommend-
ed for children undergoing cleft palate repair. Considering
that there are no reports on procedure-specific postoperative
pain management regimens available for preverbal children,
our results may suggest a fentanyl regimen for PrCA for pre-
verbal children undergoing cleft palate repair as procedure-
specific pain management (6). 
There were some limitations in our study, particularly in
the pain assessment. The parents evaluated the analgesic
responses by Wong-Baker faces pain rating scale (9), which
is usually suitable for the age of 3 and over. Pain assessment
of the children by their parents might correlate only moder-
ately with the children’s pain score and shows a poor level of
agreement (15). We only adjusted the fentanyl regimen accord-
ing to the pain score evaluated by the parents. Another poten-
tial pitfall exists in our study. Although we applied pulse
oximetry to the patients during the early study periods, fre-
quent alarms due to technical problems such as motion arti-
facts or dislodgements of sensor probe made parents anxious
and nervous and we abandoned to monitor pulse oximetry.
Therefore, for the patient’s safety, we informed parents how
to monitor respiratory patterns and rate, and recognize appear-
ance of cyanosis. Also, we asked nurse staff in ward to take
care of patient’s postoperative care as usual. 
Since the incidence of vomiting seemed to be related to the
total fentanyl consumption dose, PrCA in preverbal patients
is still challenging and needs further evaluation before rec-
ommending on a wider scale.
Apart from the analgesic responses of patient to the PrCA
modality, we got questionnaires on parents’ satisfaction of
participating in the PrCA modality after completion of the
study. Interestingly, 87% of parents were satisfied with their
participating in their children’s postoperative pain manage-
ment even though the majority of parents whose children
managed with the fentanyl regimen less than 0.5 assessed
‘Non-effective’ response. This suggested that the most of
parents were willing to be involved in the postoperative man-
agement for their children and, in particular, with PrCA.
In conclusion, the ED50 and ED95 of the fentanyl regimen
for PrCA were 0.63 and 0.83 g/kg/hr, respectively. PrCA
using fentanyl can be applied effectively for postoperative
pain management in preverbal children undergoing cleft
palate repair with a high level of parents’ satisfaction.
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